Effects of methimazole on urinary metabolomics in hyperthyroidism rats
- VernacularTitle:甲巯咪唑对甲状腺功能亢进症大鼠尿液代谢组学的影响研究
- Author:
Xu LU
1
;
Ling LI
1
,
2
;
Tao YE
3
;
Youfeng PENG
4
;
Jiaxin HE
1
;
Ning ZHANG
1
Author Information
1. School of Pharmacy，Guizhou University of Traditional Chinese Medicine，Guiyang 550025，China
2. Dept. of Pharmacy，the First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine，Guiyang 550001，China
3. Dept. of Rehabilitation，the First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine，Guiyang 550001，China
4. Dept. of Pharmacy，Dafang County Hospital of Traditional Chinese Medicine in Guizhou Province，Guiyang 551699，China
- Publication Type:Journal Article
- Keywords:
methimazole;
hyperthyroidism;
urine metabolomics;
differential metabolites;
UPLC-TOF-MS
- From:
China Pharmacy
2024;35(9):1064-1069
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To study the effects of methimazole on the urinary metabolomics of hyperthyroidism rats， and to preliminarily investigate its possible mechanism. METHODS Thirty SD rats were randomly divided into control group， model group and methimazole group， with 10 rats in each group. Except for the control group， the rats in the other two groups were given Levothyroxine sodium tablets 160 mg/kg by intragastric administration for 15 days； at the same time， methimazole group was additionally given methimazole 3.6 mg/kg daily by intragastric administration every day. The basic condition of the rats was observed， and the body weight and anal temperature were measured. After the last medication， the serum levels of triiodothyronine （T3）， tetraiodothyronine （T4）， free triiodothyronine （FT3）， free tetraiodothyronine （FT4）， and thyroid stimulating hormone （TSH） were determined； 24-hour urine was collected on the 15th day after administration. UPLC-TOF-MS was used to analyze the urine metabolomics of rats. Principal component analysis and orthogonal partial least squares-discriminant analysis were used to screen out related differential metabolites， and potential metabolic pathways were analyzed by using HMDB and KEGG. RESULTS Compared with the control group， the rectal temperature， serum levels of T3， T4， FT3 and FT4， the expressions of differential metabolites sebacic acid， cholic acid 3-O-glucuronic acid and N6， N6， N6-trimethyl-L-lysine in urine were significantly up-regulated， while body weight， serum level of TSH， the expressions of deoxycytidine and 2-oxo-4-methylthiobutanoic acid in urine were significantly down-regulated （P＜0.01）. Compared with model group， above indexes of rats were reversed significantly in methimazole group （P＜0.01 or P＜0.05）. Above five differential metabolites were mainly involved in four signaling pathways: pentose and glucuronate interaction， lysine degradation， cysteine and methionine metabolism， and pyrimidine metabolism. CONCLUSIONS Methimazole might improve hyperthyroidism by modulating the four pathways of pentose and glucuronate interaction， lysine degradation， cysteine and methionine metabolism， and pyrimidine metabolism.
